MindWalk Delivers 46% Revenue Growth and Halves Its Net Loss in Fiscal 2026
HYFT sits 41% above its 52-week low of $0.99.
Summary
MindWalk Holdings Corp. reported fiscal 2026 revenue of C$15.6 million, up 46% year-over-year, with gross margin expanding to 59% and net loss narrowing to C$13.9 million. The company also announced its first recurring platform revenue, a share repurchase program, and organic Nasdaq compliance restoration.
Key Events · Earnings and Guidance · HYFT
-
Revenue Surges 46% to C$15.6M
Full-year revenue grew 46% to C$15.6 million, with Q4 revenue up 50% to C$4.1 million, driven by the company's Bio-Native AI platform.
-
Gross Margin Expands to 59%
Gross profit rose 60% to C$9.1 million, expanding gross margin by 4.9 percentage points to 58.8%, reflecting improved operational efficiency.
-
Net Loss Narrows by Over Half
Net loss from continuing operations improved 54% to C$15.1 million, aided by the non-recurrence of C$22.7 million in prior-year non-cash impairment and amortization charges.
-
First Recurring Platform Revenue Secured
MindWalk signed its first two contracted, recurring enterprise LensAI agreements during the year, marking the first recurring platform revenue in company history.
Analysis · HYFT · Life Sciences
A breakout year is taking shape: revenue surged 46% to C$15.6 million, gross margin expanded to 59%, and the net loss was cut by more than half. The company also secured its first recurring platform revenue, regained Nasdaq compliance without dilutive financing, and authorized a share buyback — all signals that the pivot to Bio-Native AI infrastructure is gaining commercial traction and improving financial health.
How filings like this one have moved
In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, HYFT was trading at $1.40 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $67.3M. The 52-week trading range was $0.99 to $3.25. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.